SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
(Amendment No.______)
Filed by the Registrant [ X ]
Filed by a Party other than the Registrant [ ]
Check the appropriate box:
[ ] Preliminary Proxy Statement
[ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
[ ] Definitive Proxy Statement
[ ] Definitive Additional Materials
[ X ] Soliciting Material under Rule 14a-12
Salient Private Access Master Fund, L.P.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
[X] | No fee required. |
[ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
1. | Title of each class of securities to which transaction applies:
| |
2. | Aggregate number of securities to which transaction applies:
| |
3. | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
| |
4. | Proposed maximum aggregate value of transaction:
| |
5. | Total fee paid: |
[ ] Fee paid previously with preliminary proxy materials.
[ ] Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
1) | Amount Previously Paid: | |
2) | Form, Schedule or Registration Statement No.: | |
3) | Filing Party: | |
4) | Date Filed: | |
Subject: Proxy Adjournment Notification Regarding the Salient Private Access Fund
Please be advised that the Meeting of Limited Partners originally scheduled for January 21, 2021 has been adjourned until 5:00PM ET on January 28, 2021. While to date, a significant majority of the votes have been cast in favor of the Proposals in line with the Board’s unanimous recommendation that investors vote “FOR” the Proposals, a quorum of the interests entitled to vote has not yet been achieved for all Funds.
As a result, Okapi Partners LLC, the proxy solicitor for this initiative, will continue to contact Limited Partners until the necessary vote is attained. Please ask your clients to vote today.
Limited Partners have several options to vote as outlined in the proxy materials. In the interest of time, the fastest and most convenient ways to vote are:
1) | Phone: Limited Partners may call Okapi at 877-274-8654 to quickly cast their vote or ask any questions related to the proxy. Representatives are available Monday – Friday 9:00AM to 7:00PM ET. |
2) | Email: Limited Partners may email spafund@okapipartners.com and indicate their account name, address and direction they would like to vote. Financial Advisors may also cc: Okapi on an email to their client(s), asking them to reply all with confirmation on the direction of their vote. |
Limited Partners received a client cover letter [link to cover letter] summarizing the Proposals with their proxy materials in December. Please review the Proxy Statement for full details, available online at www.okapivote.com/SPA. As a reminder, The Board unanimously approved each of the Proposals and recommends that investors vote “FOR” the Proposals.
If you have any questions regarding this Transaction, please contact Okapi at 877-274-8654 or spafund@okapipartners.com. Alternatively, you may contact the Fund’s Service Desk at 800-725-9456 or spafund@salientpartners.com.
Sincerely,
Endowment Advisers, L.P.
This email is provided solely for informational purposes and is exclusively intended for the recipient. No other use or distribution of this email is authorized. Neither this email nor the information contained therein constitutes an offer to sell or a solicitation of any offer to buy any securities. Any offering or solicitation will be made to eligible investors and pursuant to the applicable PPM and other governing document.
salientpartners.com | 800-725-9456 |
CONFIDENTIALITY NOTICE: This electronic message is intended only for the use of the individual or entity to which it is addressed and may contain information that is privileged, confidential and/or exempt from disclosure under applicable laws. If the reader of this message and/or its accompanying attachment(s) is not the intended recipient, you are hereby notified that any dissemination, distribution, or copying of this communication is strictly prohibited. If you receive this communication in error, please notify us by your e-mail reply feature, delete the original message and all copies thereof from your system, and destroy all hardcopies of the message and its accompanying attachment(s).
Investing involves risk, including possible loss of principal. The value of any financial instruments or markets mentioned herein can fall as well as rise. Past performance does not guarantee future results.
Salient is the trade name for Salient Partners, L.P., which together with its subsidiaries provides asset management and advisory services. This information is being provided solely for educational purposes and is not an offer to sell or solicitation of an offer to buy an interest in any investment fund. Any such offer or solicitation may only be made by means of a confidential private offering memorandum or prospectus relating to a particular fund and only in a manner consistent with federal and applicable state securities laws.
Salient Capital, L.P., Member FINRA, SIPC, is the principal placement agent for Salient Private Access Fund. Endowment Advisers, L.P. serves as the registered investment adviser to Salient Private Access Fund. Salient Private Access Fund; Endowment Advisers, L.P. and Salient Capital, L.P. are under common control.
© 2021 Salient. All rights reserved.